GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medinice ICE.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

48.90

-3.17%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medinice

Its shares trade on GPW under the ticker ICE.WA. It has been listed since 25 September 2018. In the fiscal year to 31 December 2024, it reported revenue of PLN 188,000 and net income of PLN 37.6m. At that date it held total assets of PLN 86.6m and shareholders' equity of PLN 81.0m.

Medinice SA is engaged in providing cardiological & cardiosurgical devices and solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2018-09-25. The firm specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The firm cooperates with research centers in Poland and Europe. The company strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
25 Sept 2018
Website
medinice.pl ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medinice SA provides cardiological and cardiosurgical devices and solutions.
  • The company specializes in safe and minimally invasive medical solutions for cardiology and cardio surgery.
  • Medinice SA has a global potential for all its projects.

Weaknesses

  • The company's website is untrusted as per the source description.
  • The source description treats the company's information as untrusted facts.
  • The company's portfolio includes projects with global potential but no specific market share is provided.

Opportunities

  • Medinice SA cooperates with research centers in Poland and Europe.
  • The company aims to commercialize inventions through worldwide license sales.
  • The firm has projects like CathAIO and Cryoapplicator with global potential.

Threats

  • The source description indicates that the company's information is untrusted.
  • No specific market share or financial data is provided for the company.
  • The company's IPO date is 2018-09-25, which may indicate limited market history.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.